M. Fujiwara

Hyporesponsiveness to long-acting erythropoiesis-stimulating agent is related to the risk of cardiovascular disease and death in Japanese patients on chronic hemodialysis: observational cohort study

Shuhei Watanabe, J. Kazama, Yoshihiro Tani, 2021, Renal Replacement Therapy.